# Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction

> **NCT05222828** · PHASE2 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 38 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Carbocaine Injectable Product

## Key facts

- **NCT ID:** NCT05222828
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-22
- **Primary completion:** 2024-06-22
- **Final completion:** 2024-06-22
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05222828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05222828, "Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05222828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*